Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Gastroesophageal Reflux Disease

Clinical trial NCT00321984 · COMPLETED

Trial details

NCT number: NCT00321984
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gastroesophageal Reflux Disease

Start date: 2006-06-01
Primary completion: 2006-12-01
Enrollment: 947

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.